Drug intelligence / Profile preview

diphtheria + tetanus + pertussis + polio + haemophilus influenzae type b + varicella + measles

Development stage: Unknown
Lead developer: Sanofi
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular, Subcutaneous

Overview

This is a theoretical combination of seven vaccine components that would protect against diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b, varicella (chickenpox), and measles. Currently, no single vaccine combines all these specific components, but there are combination vaccines that include subsets of these components, such as Pentacel (DTaP-IPV/Hib) and ProQuad (MMRV).

Targets

BCR (Immunoglobulin G B Cell Receptor)

Beyond the preview

Go deeper on diphtheria + tetanus + pertussis + polio + haemophilus influenzae type b + varicella + measles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on diphtheria + tetanus + pertussis + polio + haemophilus influenzae type b + varicella + measles.

Explore the full profile